The alliance between genetic biobanks and patient organisations

the experience of the telethon network of genetic biobanks

Chiara Baldo, Lorena Casareto, Alessandra Renieri, Giuseppe Merla, Barbara Garavaglia, Stefano Goldwurm, Elena Pegoraro, Maurizio Moggio, Marina Mora, Luisa Politano, Luca Sangiorgi, Raffaella Mazzotti, Valeria Viotti, Ilaria Meloni, Maria Teresa Pellico, Chiara Barzaghi, Chiuhui Mary Wang, Lucia Monaco, Mirella Filocamo

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Rare diseases (RDs) are often neglected because they affect a small percentage of the population (6-8 %), which makes research and development of new therapies challenging processes. Easy access to high-quality samples and associated clinical data is therefore a key prerequisite for biomedical research. In this context, Genetic Biobanks are critical to developing basic, translational and clinical research on RDs. The Telethon Network of Genetic Biobanks (TNGB) is aware of the importance of biobanking as a service for patients and has started a dialogue with RD-Patient Organisations via promotion of dedicated meetings and round-tables, as well as by including their representatives on the TNGB Advisory Board. This has enabled the active involvement of POs in drafting biobank policies and procedures, including those concerning ethical issues. Here, we report on our experience with RD-Patient Organisations who have requested the services of existing biobanks belonging to TNGB and describe how these relationships were established, formalised and maintained. Results: The process of patient engagement has proven to be successful both for lay members, who increased their understanding of the complex processes of biobanking, and for professionals, who gained awareness of the needs and expectations of the people involved. This collaboration has resulted in a real interest on the part of Patient Organisations in the biobanking service, which has led to 13 written agreements designed to formalise this process. These agreements enabled the centralisation of rare genetic disease biospecimens and their related data, thus making them available to the scientific community. Conclusions: The TNGB experience has proven to be an example of good practice with regard to patient engagement in biobanking and may serve as a model of collaboration between disease-oriented Biobanks and Patient Organisations. Such collaboration serves to enhance awareness and trust and to encourage the scientific community to address research on RDs.

Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalOrphanet Journal of Rare Diseases
Volume11
Issue number1
DOIs
Publication statusPublished - Oct 24 2016

Fingerprint

Rare Diseases
Organizations
Patient Participation
Inborn Genetic Diseases
Translational Medical Research
Research
Ethics
Biomedical Research
Population

Keywords

  • Agreements
  • Biobanking
  • Networking
  • Patient involvement
  • Patient organisations
  • Rare diseases
  • Research
  • Sample and data centralisation

ASJC Scopus subject areas

  • Medicine(all)
  • Genetics(clinical)
  • Pharmacology (medical)

Cite this

The alliance between genetic biobanks and patient organisations : the experience of the telethon network of genetic biobanks. / Baldo, Chiara; Casareto, Lorena; Renieri, Alessandra; Merla, Giuseppe; Garavaglia, Barbara; Goldwurm, Stefano; Pegoraro, Elena; Moggio, Maurizio; Mora, Marina; Politano, Luisa; Sangiorgi, Luca; Mazzotti, Raffaella; Viotti, Valeria; Meloni, Ilaria; Pellico, Maria Teresa; Barzaghi, Chiara; Wang, Chiuhui Mary; Monaco, Lucia; Filocamo, Mirella.

In: Orphanet Journal of Rare Diseases, Vol. 11, No. 1, 24.10.2016, p. 1-8.

Research output: Contribution to journalArticle

Baldo, C, Casareto, L, Renieri, A, Merla, G, Garavaglia, B, Goldwurm, S, Pegoraro, E, Moggio, M, Mora, M, Politano, L, Sangiorgi, L, Mazzotti, R, Viotti, V, Meloni, I, Pellico, MT, Barzaghi, C, Wang, CM, Monaco, L & Filocamo, M 2016, 'The alliance between genetic biobanks and patient organisations: the experience of the telethon network of genetic biobanks', Orphanet Journal of Rare Diseases, vol. 11, no. 1, pp. 1-8. https://doi.org/10.1186/s13023-016-0527-7
Baldo, Chiara ; Casareto, Lorena ; Renieri, Alessandra ; Merla, Giuseppe ; Garavaglia, Barbara ; Goldwurm, Stefano ; Pegoraro, Elena ; Moggio, Maurizio ; Mora, Marina ; Politano, Luisa ; Sangiorgi, Luca ; Mazzotti, Raffaella ; Viotti, Valeria ; Meloni, Ilaria ; Pellico, Maria Teresa ; Barzaghi, Chiara ; Wang, Chiuhui Mary ; Monaco, Lucia ; Filocamo, Mirella. / The alliance between genetic biobanks and patient organisations : the experience of the telethon network of genetic biobanks. In: Orphanet Journal of Rare Diseases. 2016 ; Vol. 11, No. 1. pp. 1-8.
@article{2b6131b3291943289f820b5b2d12ab0d,
title = "The alliance between genetic biobanks and patient organisations: the experience of the telethon network of genetic biobanks",
abstract = "Background: Rare diseases (RDs) are often neglected because they affect a small percentage of the population (6-8 {\%}), which makes research and development of new therapies challenging processes. Easy access to high-quality samples and associated clinical data is therefore a key prerequisite for biomedical research. In this context, Genetic Biobanks are critical to developing basic, translational and clinical research on RDs. The Telethon Network of Genetic Biobanks (TNGB) is aware of the importance of biobanking as a service for patients and has started a dialogue with RD-Patient Organisations via promotion of dedicated meetings and round-tables, as well as by including their representatives on the TNGB Advisory Board. This has enabled the active involvement of POs in drafting biobank policies and procedures, including those concerning ethical issues. Here, we report on our experience with RD-Patient Organisations who have requested the services of existing biobanks belonging to TNGB and describe how these relationships were established, formalised and maintained. Results: The process of patient engagement has proven to be successful both for lay members, who increased their understanding of the complex processes of biobanking, and for professionals, who gained awareness of the needs and expectations of the people involved. This collaboration has resulted in a real interest on the part of Patient Organisations in the biobanking service, which has led to 13 written agreements designed to formalise this process. These agreements enabled the centralisation of rare genetic disease biospecimens and their related data, thus making them available to the scientific community. Conclusions: The TNGB experience has proven to be an example of good practice with regard to patient engagement in biobanking and may serve as a model of collaboration between disease-oriented Biobanks and Patient Organisations. Such collaboration serves to enhance awareness and trust and to encourage the scientific community to address research on RDs.",
keywords = "Agreements, Biobanking, Networking, Patient involvement, Patient organisations, Rare diseases, Research, Sample and data centralisation",
author = "Chiara Baldo and Lorena Casareto and Alessandra Renieri and Giuseppe Merla and Barbara Garavaglia and Stefano Goldwurm and Elena Pegoraro and Maurizio Moggio and Marina Mora and Luisa Politano and Luca Sangiorgi and Raffaella Mazzotti and Valeria Viotti and Ilaria Meloni and Pellico, {Maria Teresa} and Chiara Barzaghi and Wang, {Chiuhui Mary} and Lucia Monaco and Mirella Filocamo",
year = "2016",
month = "10",
day = "24",
doi = "10.1186/s13023-016-0527-7",
language = "English",
volume = "11",
pages = "1--8",
journal = "Orphanet Journal of Rare Diseases",
issn = "1750-1172",
publisher = "BioMed Central Ltd.",
number = "1",

}

TY - JOUR

T1 - The alliance between genetic biobanks and patient organisations

T2 - the experience of the telethon network of genetic biobanks

AU - Baldo, Chiara

AU - Casareto, Lorena

AU - Renieri, Alessandra

AU - Merla, Giuseppe

AU - Garavaglia, Barbara

AU - Goldwurm, Stefano

AU - Pegoraro, Elena

AU - Moggio, Maurizio

AU - Mora, Marina

AU - Politano, Luisa

AU - Sangiorgi, Luca

AU - Mazzotti, Raffaella

AU - Viotti, Valeria

AU - Meloni, Ilaria

AU - Pellico, Maria Teresa

AU - Barzaghi, Chiara

AU - Wang, Chiuhui Mary

AU - Monaco, Lucia

AU - Filocamo, Mirella

PY - 2016/10/24

Y1 - 2016/10/24

N2 - Background: Rare diseases (RDs) are often neglected because they affect a small percentage of the population (6-8 %), which makes research and development of new therapies challenging processes. Easy access to high-quality samples and associated clinical data is therefore a key prerequisite for biomedical research. In this context, Genetic Biobanks are critical to developing basic, translational and clinical research on RDs. The Telethon Network of Genetic Biobanks (TNGB) is aware of the importance of biobanking as a service for patients and has started a dialogue with RD-Patient Organisations via promotion of dedicated meetings and round-tables, as well as by including their representatives on the TNGB Advisory Board. This has enabled the active involvement of POs in drafting biobank policies and procedures, including those concerning ethical issues. Here, we report on our experience with RD-Patient Organisations who have requested the services of existing biobanks belonging to TNGB and describe how these relationships were established, formalised and maintained. Results: The process of patient engagement has proven to be successful both for lay members, who increased their understanding of the complex processes of biobanking, and for professionals, who gained awareness of the needs and expectations of the people involved. This collaboration has resulted in a real interest on the part of Patient Organisations in the biobanking service, which has led to 13 written agreements designed to formalise this process. These agreements enabled the centralisation of rare genetic disease biospecimens and their related data, thus making them available to the scientific community. Conclusions: The TNGB experience has proven to be an example of good practice with regard to patient engagement in biobanking and may serve as a model of collaboration between disease-oriented Biobanks and Patient Organisations. Such collaboration serves to enhance awareness and trust and to encourage the scientific community to address research on RDs.

AB - Background: Rare diseases (RDs) are often neglected because they affect a small percentage of the population (6-8 %), which makes research and development of new therapies challenging processes. Easy access to high-quality samples and associated clinical data is therefore a key prerequisite for biomedical research. In this context, Genetic Biobanks are critical to developing basic, translational and clinical research on RDs. The Telethon Network of Genetic Biobanks (TNGB) is aware of the importance of biobanking as a service for patients and has started a dialogue with RD-Patient Organisations via promotion of dedicated meetings and round-tables, as well as by including their representatives on the TNGB Advisory Board. This has enabled the active involvement of POs in drafting biobank policies and procedures, including those concerning ethical issues. Here, we report on our experience with RD-Patient Organisations who have requested the services of existing biobanks belonging to TNGB and describe how these relationships were established, formalised and maintained. Results: The process of patient engagement has proven to be successful both for lay members, who increased their understanding of the complex processes of biobanking, and for professionals, who gained awareness of the needs and expectations of the people involved. This collaboration has resulted in a real interest on the part of Patient Organisations in the biobanking service, which has led to 13 written agreements designed to formalise this process. These agreements enabled the centralisation of rare genetic disease biospecimens and their related data, thus making them available to the scientific community. Conclusions: The TNGB experience has proven to be an example of good practice with regard to patient engagement in biobanking and may serve as a model of collaboration between disease-oriented Biobanks and Patient Organisations. Such collaboration serves to enhance awareness and trust and to encourage the scientific community to address research on RDs.

KW - Agreements

KW - Biobanking

KW - Networking

KW - Patient involvement

KW - Patient organisations

KW - Rare diseases

KW - Research

KW - Sample and data centralisation

UR - http://www.scopus.com/inward/record.url?scp=84992220762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992220762&partnerID=8YFLogxK

U2 - 10.1186/s13023-016-0527-7

DO - 10.1186/s13023-016-0527-7

M3 - Article

VL - 11

SP - 1

EP - 8

JO - Orphanet Journal of Rare Diseases

JF - Orphanet Journal of Rare Diseases

SN - 1750-1172

IS - 1

ER -